We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$22.9B
AUM Growth
+$801M
Cap. Flow
+$1.26B
Cap. Flow %
5.48%
Top 10 Hldgs %
26.16%
Holding
1,655
New
269
Increased
651
Reduced
446
Closed
272

Top Buys

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$159M
2
TRP icon
TC Energy
TRP
+$105M
3
MRVL icon
Marvell Technology
MRVL
+$92.4M
4
INFY icon
Infosys
INFY
+$83.4M
5
PAAS icon
Pan American Silver
PAAS
+$81.1M

Sector Composition

Rank Sector Weight
1 Financials 23.76%
2 Technology 17.69%
3 Industrials 12.67%
4 Energy 11.54%
5 Materials 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGD
101
DELISTED
New Gold Inc
NGD
$42.7M 0.19%
11,545,982
-418,800
-4% -$1.24M
OR icon
102
OR Royalties Inc
OR
$6.31B
$42.5M 0.19%
2,013,796
-855,504
-30% -$16.4M
KO icon
103
Coca-Cola
KO
$373B
$42.3M 0.18%
590,653
+479,458
+431% +$32M
QFIN icon
104
Qfin Holdings
QFIN
$1.53B
$42M 0.18%
934,279
+14,312
+2% +$592K
NTAP icon
105
NetApp
NTAP
$39.6B
$38.9M 0.17%
442,697
-33,163
-7% -$3.67M
P
106
Everpure Inc
P
$37B
$38.7M 0.17%
873,267
-84,432
-9% -$5.09M
BIIB icon
107
Biogen
BIIB
$30.9B
$38M 0.17%
277,834
+137,514
+98% +$19.7M
BMRN icon
108
BioMarin Pharmaceuticals
BMRN
$13.6B
$36.9M 0.16%
521,349
+164,853
+46% +$11.1M
PTON icon
109
Peloton Interactive
PTON
$2.38B
$36.9M 0.16%
5,831,180
+1,603,326
+38% +$12.6M
ZLAB icon
110
Zai Lab
ZLAB
$2.86B
$36.5M 0.16%
1,009,020
+167,285
+20% +$5.15M
V icon
111
Visa
V
$671B
$36.3M 0.16%
103,488
+13,317
+15% +$4.51M
HIMS icon
112
Hims & Hers Health
HIMS
$6.99B
$35.9M 0.16%
1,216,499
+43,525
+4% +$1.62M
ORLA
113
DELISTED
Orla Mining
ORLA
$35.9M 0.16%
3,843,000
+2,094,800
+120% +$14.9M
MA icon
114
Mastercard
MA
$490B
$35.5M 0.16%
64,807
+53,258
+461% +$29M
IBM icon
115
IBM
IBM
$222B
$35.2M 0.15%
141,673
+44,051
+45% +$10.8M
PGR icon
116
Progressive
PGR
$121B
$35.1M 0.15%
124,083
-39,157
-24% -$10.2M
QRVO icon
117
Qorvo
QRVO
$8.67B
$34.7M 0.15%
478,742
+266,332
+125% +$20.3M
ROK icon
118
Rockwell Automation
ROK
$50.1B
$34.4M 0.15%
133,108
+126,709
+1,980% +$35.3M
PYPL icon
119
PayPal
PYPL
$50.6B
$34M 0.15%
521,083
+427,636
+458% +$33.3M
MDGL icon
120
Madrigal Pharmaceuticals
MDGL
$12.4B
$33.9M 0.15%
102,360
-928
-0.9% -$305K
MS icon
121
Morgan Stanley
MS
$342B
$33.9M 0.15%
290,240
+178,906
+161% +$23.1M
ETSY icon
122
Etsy
ETSY
$7.31B
$33.6M 0.15%
711,454
+415,942
+141% +$21.3M
EXAS
123
DELISTED
Exact Sciences
EXAS
$33.3M 0.15%
769,250
+219,988
+40% +$11.1M
PG icon
124
Procter & Gamble
PG
$335B
$32.9M 0.14%
192,923
+106,008
+122% +$17.8M
VRT icon
125
Vertiv
VRT
$111B
$32.8M 0.14%
453,752
+369,149
+436% +$39.3M

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2025 Portfolio in Review

As of Q1 2025, Connor, Clark & Lunn Investment Management (CC&L) held 1,655 positions worth $22.9B, up 3.6% from $22.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) deployed $1.26B of net new capital in Q1 2025, opening 269 new positions and adding to 651 existing holdings. Its largest new stake was Advanced Micro Devices: 709,028 shares worth $72.8M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Celestica, an estimated $111M trimmed.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2025 buy was Advanced Micro Devices: 709,028 shares worth $72.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Franco-Nevada in Q1 2025, an estimated $159M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2025 reduction was Celestica, cutting an estimated $111M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q1 2025, selling an estimated $28.1M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 26% of its $22.9B portfolio in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 269 new positions and closed 272 in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 3.6% quarter-over-quarter to $22.9B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.